Cohesion CoSeal
This article was originally published in The Gray Sheet
Executive Summary
Expansion of the firm's 20-rep U.S. sales force to 25 sales and support staffers is expected by year-end. Cohesion also recently executed contracts with five independent reps in order to meet demand for the surgical sealant. Revenue from CoSeal, approved via PMA in December 2001, has exceeded $1 mil. since its launch in January (1"The Gray Sheet" Dec. 24, 2001, p. 13). The company's Adhibit surgical adhesion prevention gel also has received a CE mark for use in cardiac surgery, and an IDE for a U.S. clinical trial will be filed in early 2003...